SCHEMBL10032703

SCHEMBL10032703

Cc1cc(=O)c(OCc2ccccc2)c(C(=O)ON2C(=O)CCC2=O)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
IDH1 O75874 1/20 0.42
HPGD P15428 2/20 0.39
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 2/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
RAB9A P51151 1/20 0.38
EDNRA P25101 1/20 0.36
PSMB8 P28062 1/20 0.36
PSMB5 P28074 1/20 0.36
MMP3 P08254 2/20 0.36
MMP12 P39900 2/20 0.36
CREB1 P16220 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13395960 0.87 LMNA (0.46) LMNAGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL338697 0.81 IDH1 (0.50) LMNAGAAIDH1HPGDALDH1A1
SCHEMBL8268657 0.81 LMNA (0.36) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL1772322 0.81 LMNA (0.54) LMNAGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL338935 0.79 IDH1 (0.48) LMNAGAAIDH1HPGDALDH1A1
SCHEMBL337855 0.77 IDH1 (0.49) LMNAGAAIDH1HPGDALDH1A1
SCHEMBL5551769 0.76 LMNA (0.42) LMNAGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL339006 0.75 BRD4 (0.47) LMNAIDH1HPGDALDH1A1SMN1; SMN2
SCHEMBL8145094 0.74 IDH1 (0.44) LMNAGAAIDH1HPGDALDH1A1
SCHEMBL339672 0.73 KMT2A (0.53) IDH1HPGDALDH1A1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318945-B2 Metalloprotein inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-11-27 US disclosed
US-20120041032-A1 METALLOPROTEIN INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2012-02-16 US disclosed
US-8008510-B2 Metalloprotein inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-08-30 US disclosed
US-7786316-B2 Metalloprotein inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-31 US disclosed
US-20100173952-A1 METALLOPROTEIN INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) 2010-07-08 US disclosed
US-7705164-B2 Metalloprotein inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-27 US disclosed
US-20100098640-A1 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2010-04-22 US disclosed
US-20090286987-A1 METALLOPROTEIN INHIBITORS REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO UCSD TECHNOLOGY TRANSFER OFFICE (US) 2009-11-19 US disclosed
US-7579486-B2 Metalloprotein inhibitors REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2009-08-25 US disclosed
US-20080161362-A1 Metalloprotein Inhibitors REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO UCSD TECHNOLOGY TRANSFER OFFICE (US) 2008-07-03 US disclosed
US-20070117848-A1 METALLOPROTEIN INHIBITORS REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286987-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885IDH1 543/4885
US-20080161362-A1 Metalloprotein Inhibitors SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885IDH1 543/4885
US-20100173952-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885IDH1 543/4885
US-20070117848-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885IDH1 543/4885
US-20120041032-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885IDH1 543/4885
US-20100098640-A1 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation DNM1, BET1, FOLH1 LMNA 2576/4885GAA 594/4885IDH1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.